Research Collaboration

Biomed Industries™welcomes an opportunity to form collaboration and business relationship with biopharmaceutical companies to achieve our common goals. Principal elements of the Company's research strategy include the following:

* Targeting large markets with unmet medical needs: Biomed targets large pharmaceutical markets that are not adequately served by existing therapies. The Company focuses on antiviral drugs for the prevention and treatment of coronavirus, in addition to new drugs for prevention and treatment of neurological disorders.

* Retaining commercial rights to product candidates: The Company will seek to retain significant commercial rights to its product candidates by conducting clinical development activities at least through initial proof of efficacy in humans. For larger and more complex clinical trials, and for worldwide marketing and distribution, Biomed Corporation intends to seek strategic collaborations with large pharmaceutical companies.

* Protecting proprietary position with broad patent coverage: Biomed has built a strong domestic and international patent position protecting its rich compound and intellectual property estate.

For further information on potential research collaboration, please contact us online at Contact Form. Thank you.